Literature DB >> 21060063

Of Ephs and ephrins: companies target guidance molecules in cancer.

Ken Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21060063     DOI： 10.1093/jnci/djq479

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.

Authors:  Pierre Saintigny; Shaohua Peng; Li Zhang; Banibrata Sen; Ignacio I Wistuba; Scott M Lippman; Luc Girard; John D Minna; John V Heymach; Faye M Johnson
Journal:  Mol Cancer Ther       Date:  2012-07-17       Impact factor: 6.261

Review 2.  Role of Eph/ephrin tyrosine kinase in malignant glioma.

Authors:  Mitsutoshi Nakada; Yutaka Hayashi; Jun-ichiro Hamada
Journal:  Neuro Oncol       Date:  2011-08-19       Impact factor: 12.300

3.  Promiscuous and specific recognition among ephrins and Eph receptors.

Authors:  Dandan Dai; Qiang Huang; Ruth Nussinov; Buyong Ma
Journal:  Biochim Biophys Acta       Date:  2014-07-10

4.  EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.

Authors:  S D Wang; P Rath; B Lal; J-P Richard; Y Li; C R Goodwin; J Laterra; S Xia
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.